AtonRa Partners
- SEC CIK
- 0001846445
- Latest filing
- Feb 5, 2024
NRIX holding history
Nurix Therapeutics, Inc. in every 13F filed by AtonRa Partners, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
NRIX overviewAll 13F holders of NRIXFull Q4 2023 holdings
- Shares (Q4 2023)
- 21,102
- Value
- $217.8K
- % of portfolio
- 0.4%
- Quarters held
- 11
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2023 | 21,102 | $217.8K | 0.4% | −3,125−12.9% | Reduced | Holders |
| Q3 2023 | 24,227 | $190.4K | 0.4% | −5,915−19.6% | Reduced | Holders |
| Q2 2023 | 30,142 | $301.1K | 0.5% | −2,792−8.5% | Reduced | Holders |
| Q1 2023 | 32,934 | $292.5K | 0.4% | −3,994−10.8% | Reduced | Holders |
| Q4 2022 | 36,928 | $405.5K | 0.5% | −9,987−21.3% | Reduced | Holders |
| Q3 2022 | 46,915 | $611.0K | 0.6% | −2,302−4.7% | Reduced | Holders |
| Q2 2022 | 49,217 | $624.0K | 0.6% | +1,753+3.7% | Added | Holders |
| Q1 2022 | 47,464 | $665.0K | 0.4% | +172+0.4% | Added | Holders |
| Q4 2021 | 47,292 | $1.37M | 0.5% | +7,080+17.6% | Added | Holders |
| Q3 2021 | 40,212 | $1.21M | 0.4% | +16,601+70.3% | Added | Holders |
| Q2 2021 | 23,611 | $626.0K | 0.2% | +23,611 | New | Holders |